Volver a Agenda
Session Chair(s)
Nicole Turner, MBA
Director, Oncology Data Science Portfolio Management, Global Development
Janssen R&D, LLC, United States
Learning Objective : Discuss primary and secondary data components and analysis techniques that are commonly used to provide a comprehensive approach to operational feasibility; Describe the limitations associated with investigator primary research methods at early stages of clinical planning; Explain potential mitigation strategies and opportunities, given our current investigator primary research methods and objectives.
Speaker(s)
Investigator Enrollment Estimates: An Assessment of Accuracy in Comparison to Actual Enrollment Performance
Nicole Turner, MBA
Janssen R&D, LLC, United States
Director, Oncology Data Science Portfolio Management, Global Development
Innovative Approach to Clinical Trial Feasibility Through an Investigator Consultation Network
Lisa Palladino-Kim, EDD, MS
Rutgers School of Health Professions Clin Research Mgmt, United States
Lecturer / Director of Capstone
Establishing the Four Pillars of Data-driven Feasibility: Best Practices and Tools for Patient Recruitment Planning
Travis D. Caudill
INC Research, United States
Director, Feasibility & Site Identification
¿Tiene una cuenta?